OCT 11, 2018 06:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Homing in on RET; New Precision Medicine Approaches in RET-Driven Cancers

1 1 15

  • Medical Director, Head and Neck Oncology, Massachusetts General Hospital
      Dr. Lori Wirth is Medical Director of Massachusetts General Hospital's Center for Head and Neck Cancers and Associate Professor in Medicine at Harvard Medical School. Dr. Wirth received her BA from Brown University and MD from Columbia's College of Physicians and Surgeons. She trained at New York Presbyterian Hospital and Dana-Farber/Harvard Cancer Center.

      Dr. Wirth is an authority in advanced thyroid cancer and head and neck oncology, with expertise new therapies for head and neck and thyroid cancers. Her research focuses on clinical trials and leveraging translational data to maximize the impact of trial outcomes.

      In addition to overseeing the Center for Head and Neck Cancers, Dr. Wirth co-directs Mass General/Mass Eye and Ear's Advanced Thyroid Cancer Clinic. Dr. Wirth is Immediate Past Chairperson of the International Thyroid Oncology Group, and sits on a number of national and international oncology committees, including NCCN's Thyroid Committee and ABIM's Medical Oncology Exam Committee.


    Show Resources
    Loading Comments...